CORD-19:16a812de72963ceda960a168236e8dbe91832d45 / 14418-14683 JSONTXT

{"project":"CORD-19-SciBite-sentences","denotations":[{"id":"T140","span":{"begin":22,"end":265},"obj":"http://purl.obolibrary.org/obo/GO0030424"},{"id":"T142","span":{"begin":22,"end":265},"obj":"http://purl.obolibrary.org/obo/GO0040007"},{"id":"T143","span":{"begin":22,"end":265},"obj":"http://purl.obolibrary.org/obo/GO0005883"}],"attributes":[{"id":"A140","pred":"class","subj":"T140","obj":"GOONTOL"},{"id":"A142","pred":"class","subj":"T142","obj":"GOONTOL"},{"id":"A143","pred":"class","subj":"T143","obj":"GOONTOL"}],"text":"Likewise, Jean et al. (2002) have described a dramatic reduction in neurofilament staining of axons within lysolecithin-damaged areas, and have shown that acceleration of remyelination with plateletderived growth factor ameliorates this loss of axon immunolabeling."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T77","span":{"begin":0,"end":265},"obj":"Sentence"}],"text":"Likewise, Jean et al. (2002) have described a dramatic reduction in neurofilament staining of axons within lysolecithin-damaged areas, and have shown that acceleration of remyelination with plateletderived growth factor ameliorates this loss of axon immunolabeling."}

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T77","span":{"begin":0,"end":265},"obj":"Sentence"},{"id":"TextSentencer_T77","span":{"begin":0,"end":265},"obj":"Sentence"},{"id":"T65746","span":{"begin":0,"end":265},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Likewise, Jean et al. (2002) have described a dramatic reduction in neurofilament staining of axons within lysolecithin-damaged areas, and have shown that acceleration of remyelination with plateletderived growth factor ameliorates this loss of axon immunolabeling."}